Current understanding of methamphetamine-associated dopaminergic neurodegeneration and psychotoxic behaviors (Q39153958)

9 September 2017

Current understanding of methamphetamine-associated dopaminergic neurodegeneration and psychotoxic behaviors (English)

1 reference

9 September 2017

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28243833%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

author name string

Eun-Joo Shin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28243833%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Duy-Khanh Dang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28243833%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

The-Vinh Tran

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28243833%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Hai-Quyen Tran

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28243833%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Ji Hoon Jeong

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28243833%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Seung-Yeol Nah

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28243833%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Choon-Gon Jang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28243833%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Kiyofumi Yamada

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28243833%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Toshitaka Nabeshima

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28243833%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

publication date

28 February 2017

1 reference

Archives of Pharmacal Research

9 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28243833%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28243833%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

page(s)

403-428

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28243833%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28243833%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12272-017-0897-y

14 June 2020

exact match

0 references

cites work

Olanzapine and risperidone block a high dose of methamphetamine-induced schizophrenia-like behavioral abnormalities and accompanied apoptosis in the medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Effects of aripiprazole and haloperidol on progression to schizophrenia-like behavioural abnormalities and apoptosis in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine causes lipid peroxidation and an increase in superoxide dismutase activity in the rat striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Zinc rescues dopaminergic SK-N-SH cell lines from methamphetamine-induced toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Longitudinal clinical course following pharmacological treatment of methamphetamine psychosis which persists after long-term abstinence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Effects of repeated high-dose methamphetamine and ceftriaxone post-treatments on tissue content of dopamine and serotonin as well as glutamate and glutamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

History of the methamphetamine problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Involvement of pallidotegmental neurons in methamphetamine- and MK-801-induced impairment of prepulse inhibition of the acoustic startle reflex in mice: reversal by GABAB receptor agonist baclofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Dopamine D(1) receptor deletion strongly reduces neurotoxic effects of methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine-induced increase in striatal p53 DNA-binding activity is attenuated in Cu,Zn-superoxide dismutase transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine-induced neurotoxicity in mouse brain is attenuated by ketoprofen, a non-steroidal anti-inflammatory drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Mitochondria: key players in the neurotoxic effects of amphetamines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Persistent antagonism of methamphetamine-induced dopamine release in rats pretreated with GBR12909 decanoate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Involvement of dopamine receptors in binge methamphetamine-induced activation of endoplasmic reticulum and mitochondrial stress pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Impaired object recognition memory following methamphetamine, but not p-chloroamphetamine- or d-amphetamine-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine influences on recognition memory: comparison of escalating and single-day dosing regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Short toxic methamphetamine schedule impairs object recognition task in male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Minocycline restores striatal tyrosine hydroxylase in GDNF heterozygous mice but not in methamphetamine-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Deficits in behavioral sensitization and dopaminergic responses to methamphetamine in adenylyl cyclase 1/8-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Phenobarbital and dizocilpine can block methamphetamine-induced neurotoxicity in mice by mechanisms that are independent of thermoregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine-induced short-term increase and long-term decrease in spatial working memory affects protein Kinase M zeta (PKMζ), dopamine, and glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Regulation of cell apoptosis by protein kinase c delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine use and schizophrenia: a population-based cohort study in California

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

HIV-1 protein Tat potentiation of methamphetamine-induced decreases in evoked overflow of dopamine in the striatum of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Suppression of autophagy precipitates neuronal cell death following low doses of methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Identification of Piccolo as a regulator of behavioral plasticity and dopamine transporter internalization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Psychoactive substrates stimulate dopamine transporter phosphorylation and down-regulation by cocaine-sensitive and protein kinase C-dependent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Genetic variation of GRIN1 confers vulnerability to methamphetamine-dependent psychosis in a Thai population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Effects of repeated electroconvulsive shock on methamphetamine-induced behavioral abnormalities in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Protective effects of the antioxidant sulforaphane on behavioral changes and neurotoxicity in mice after the administration of methamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Tetrahydropalmatine protects against methamphetamine-induced spatial learning and memory impairment in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Memantine protects against amphetamine derivatives-induced neurotoxic damage in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Long-lasting alterations in 5-HT2A receptor after a binge regimen of methamphetamine in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Repeated weekly exposure to MDMA, methamphetamine or their combination: long-term behavioural and neurochemical effects in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

A review of the clinical pharmacology of methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: a population-based assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Social isolation stress significantly enhanced the disruption of prepulse inhibition in mice repeatedly treated with methamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Inhibition of protein kinase (PK) Cδ attenuates methamphetamine-induced dopaminergic toxicity via upregulation of phosphorylation of tyrosine hydroxylase at Ser40 by modulation of protein phosphatase 2A and PKA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Apocynin prevents mitochondrial burdens, microglial activation, and pro-apoptosis induced by a toxic dose of methamphetamine in the striatum of mice via inhibition of p47phox activation by ERK

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Major physical and psychological harms of methamphetamine use

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine-induced neuronal damage: a possible role for free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

PKC-δ signalling pathway is involved in H9c2 cells differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Markers associated with sex differences in methamphetamine-induced striatal dopamine neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

The hippocampus and declarative memory: cognitive mechanisms and neural codes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Striatal subregions are differentially vulnerable to the neurotoxic effects of methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Mitochondrial translocation of p53 mediates release of cytochrome c and hippocampal CA1 neuronal death after transient global cerebral ischemia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Levels of 4-hydroxynonenal and malondialdehyde are increased in brain of human chronic users of methamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine-induced TNF-alpha gene expression and activation of AP-1 in discrete regions of mouse brain: potential role of reactive oxygen intermediates and lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Occurrence of neuronal inclusions combined with increased nigral expression of alpha-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Is there a role for nitric oxide in methamphetamine-induced dopamine terminal degeneration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Effect of antioxidant N-acetyl-L-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Aripiprazole attenuates established behavioral sensitization induced by methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

NADPH oxidases: novel therapeutic targets for neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine psychosis: epidemiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Neuroprotective action of MPEP, a selective mGluR5 antagonist, in methamphetamine-induced dopaminergic neurotoxicity is associated with a decrease in dopamine outflow and inhibition of hyperthermia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine-induced early increase of IL-6 and TNF-alpha mRNA expression in the mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Modafinil improves methamphetamine-induced object recognition deficits and restores prefrontal cortex ERK signaling in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Effect of a neurotoxic dose regimen of (+)-methamphetamine on behavior, plasma corticosterone, and brain monoamines in adult C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration : early loss of TH in striosomes after methamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Nrf2 deficiency potentiates methamphetamine-induced dopaminergic axonal damage and gliosis in the striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine-associated psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine-induced deficits of brain monoaminergic neuronal markers: distal axotomy or neuronal plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Reduced vesicular storage of dopamine exacerbates methamphetamine-induced neurodegeneration and astrogliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Extended access to methamphetamine self-administration affects sensorimotor gating in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

The anti-(+)-methamphetamine monoclonal antibody mAb7F9 attenuates acute (+)-methamphetamine effects on intracranial self-stimulation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Protective effects of N-acetyl-L-cysteine on the reduction of dopamine transporters in the striatum of monkeys treated with methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

A neurotoxic dose of methamphetamine induces gene expression of Homer 1a, but not Homer 1b or 1c, in the striatum and nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Protective effects of minocycline on the reduction of dopamine transporters in the striatum after administration of methamphetamine: a positron emission tomography study in conscious monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

The human dopamine transporter forms a tetramer in the plasma membrane: cross-linking of a cysteine in the fourth transmembrane segment is sensitive to cocaine analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Delta opioid peptide [D-Ala2, D-Leu5]enkephalin causes a near complete blockade of the neuronal damage caused by a single high dose of methamphetamine: examining the role of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Prepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Effect of +-methamphetamine on path integration learning, novel object recognition, and neurotoxicity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

The effects of GABAA and NMDA receptors in the shell-accumbens on spatial memory of METH-treated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine-induced serotonin neurotoxicity is attenuated in p53-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Long-term protective effects of methamphetamine preconditioning against single-day methamphetamine toxic challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Analysis of VMAT2 binding after methamphetamine or MPTP treatment: disparity between homogenates and vesicle preparations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Protective effects of interferon-gamma against methamphetamine-induced neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

The neurobiology of methamphetamine induced psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Oxidative stress status in recently abstinent methamphetamine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Effect of an mGlu2/3 receptor antagonist on depressive behavior induced by withdrawal from chronic treatment with methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Selenium, an antioxidant, protects against methamphetamine-induced dopaminergic neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine-induced alteration in striatal p53 and bcl-2 expressions in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Effect of melatonin on methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Comparison between the role of the neuronal and inducible nitric oxide synthase in methamphetamine-induced neurotoxicity and sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Differential response of nNOS knockout mice to MDMA ("ecstasy")- and methamphetamine-induced psychomotor sensitization and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine causes differential regulation of pro-death and anti-death Bcl-2 genes in the mouse neocortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

In vivo effects of methamphetamine on HIV-1 replication: A population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Transcriptional regulation of pro-apoptotic protein kinase Cdelta: implications for oxidative stress-induced neuronal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

α-Synuclein negatively regulates protein kinase Cδ expression to suppress apoptosis in dopaminergic neurons by reducing p300 histone acetyltransferase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Potentiation of methamphetamine neurotoxicity by intrastriatal lipopolysaccharide administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Differential roles of dopamine D1 and D2 receptor-containing neurons of the nucleus accumbens shell in behavioral sensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Clinical features of methamphetamine-induced paranoia and preliminary genetic association with DBH-1021C→T in a Thai treatment cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Repeated methamphetamine treatment impairs recognition memory through a failure of novelty-induced ERK1/2 activation in the prefrontal cortex of mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Selective serotonin reuptake inhibitors, fluoxetine and paroxetine, attenuate the expression of the established behavioral sensitization induced by methamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Role of Proteolytic Activation of Protein Kinase Cδ in Oxidative Stress-Induced Apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Neuroprotective effect of resveratrol against methamphetamine-induced dopaminergic apoptotic cell death in a cell culture model of neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Caspase‐3 dependent proteolytic activation of protein kinase Cδ mediates and regulates 1‐methyl‐4‐phenylpyridinium (MPP+)‐induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Tyrosine phosphorylation regulates the proteolytic activation of protein kinase Cdelta in dopaminergic neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Pharmacological action of Panax ginseng on the behavioral toxicities induced by psychotropic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Expression of cyclin D3 through Sp1 sites by histone deacetylase inhibitors is mediated with protein kinase C-delta (PKC-delta) signal pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Brain serotonin transporter in human methamphetamine users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Caffeic acid protects tissue antioxidants and DNA content in methamphetamine induced tissue toxicity in Sprague Dawley rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine self-administration results in persistent dopaminergic pathology: implications for Parkinson's disease risk and reward-seeking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

CREB phosphorylation regulates striatal transcriptional responses in the self-administration model of methamphetamine addiction in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Microglia: a sensor for pathological events in the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Mitochondrial membrane permeabilization in cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Escalating dose-multiple binge methamphetamine exposure results in degeneration of the neocortex and limbic system in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Dopamine quinones activate microglia and induce a neurotoxic gene expression profile: relationship to methamphetamine-induced nerve ending damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKCδ in cell culture and animal models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine-sensitized mice are accompanied by memory impairment and reduction of N-methyl-d-aspartate receptor ligand binding in the prefrontal cortex and hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine enhances HIV infection of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Provocative tests with psychostimulant drugs in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methylphenidate response, psychopathology and tardive dyskinesia as predictors of relapse in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine-induced neurotoxicity linked to ubiquitin-proteasome system dysfunction and autophagy-related changes that can be modulated by protein kinase C delta in dopaminergic neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Prefrontal glutamate correlates of methamphetamine sensitization and preference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Antipsychotic property of a muscarinic receptor agonist in animal models for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

BDNF deficiency and young-adult methamphetamine induce sex-specific effects on prepulse inhibition regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine influences on brain and behavior: unsafe at any speed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Characterization of binge-dosed methamphetamine-induced neurotoxicity and neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Long-term methamphetamine administration in the vervet monkey models aspects of a human exposure: brain neurotoxicity and behavioral profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Brain antioxidant systems in human methamphetamine users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Knockdown of dopamine D₂ receptors in the nucleus accumbens core suppresses methamphetamine-induced behaviors and signal transduction in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Nicotine ameliorates impairment of working memory in methamphetamine-treated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Conditioned place preference and locomotor sensitization after repeated administration of cocaine or methamphetamine in rats treated with epidermal growth factor during the neonatal period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Why is parkinsonism not a feature of human methamphetamine users?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: neural consequences and comparison with methamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Repeated methamphetamine treatment impairs spatial working memory in rats: reversal by clozapine but not haloperidol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine enhances HIV-1 infectivity in monocyte derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Diversity and plasticity of microglial cells in psychiatric and neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Association analysis of SOD2 variants with methamphetamine psychosis in Japanese and Taiwanese populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Lamotrigine blocks the initiation and expression of repeated high-dose methamphetamine-induced prepulse inhibition deficit in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Ginsenoside Re protects methamphetamine-induced mitochondrial burdens and proapoptosis via genetic inhibition of protein kinase C δ in human neuroblastoma dopaminergic SH-SY5Y cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Association between quantitative EEG and neurocognition in methamphetamine-dependent volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Liposomal melatonin rescues methamphetamine-elicited mitochondrial burdens, pro-apoptosis, and dopaminergic degeneration through the inhibition PKCδ gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Galantamine ameliorates the impairment of recognition memory in mice repeatedly treated with methamphetamine: involvement of allosteric potentiation of nicotinic acetylcholine receptors and dopaminergic-ERK1/2 systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Chronic methamphetamine exposure produces a delayed, long-lasting memory deficit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Repeated administration of methamphetamine damages cells in the somatosensory cortex: overlap with cytochrome oxidase-rich barrels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Genetic Association Analysis of NOS3 and Methamphetamine-Induced Psychosis Among Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Genetic Association Analysis of NOS1 and Methamphetamine-Induced Psychosis Among Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Fyn Kinase Regulates Microglial Neuroinflammatory Responses in Cell Culture and Animal Models of Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Effect of alpha-tocopherol and deferoxamine on methamphetamine-induced neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Farnesyltransferase inhibitor attenuates methamphetamine toxicity-induced Ras proteins activation and cell death in neuroblastoma SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Effect of methamphetamine on glutamate-positive neurons in the adult and developing rat somatosensory cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Disrupted ERK signaling during cortical development leads to abnormal progenitor proliferation, neuronal and network excitability and behavior, modeling human neuro-cardio-facial-cutaneous and related syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Effect of ischemic preconditioning on mitochondrial dysfunction and mitochondrial p53 translocation after transient global cerebral ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Modafinil abrogates methamphetamine-induced neuroinflammation and apoptotic effects in the mouse striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Loss of object recognition memory produced by extended access to methamphetamine self-administration is reversed by positive allosteric modulation of metabotropic glutamate receptor 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine-induced changes in the object recognition memory circuit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Sex differences in escalation of methamphetamine self-administration: cognitive and motivational consequences in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

The neurobiology of relapse in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

7,8-Dihydroxyflavone, a TrkB agonist, attenuates behavioral abnormalities and neurotoxicity in mice after administration of methamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

BDNF-TrkB signaling in the nucleus accumbens shell of mice has key role in methamphetamine withdrawal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Prospective memory impairment in former users of methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Mechanisms of methamphetamine-induced dopaminergic neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Extended methamphetamine self-administration enhances reinstatement of drug seeking and impairs novel object recognition in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Neurologic manifestations of chronic methamphetamine abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Intracellular methamphetamine prevents the dopamine-induced enhancement of neuronal firing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Impact of methamphetamine on infection and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Environmental neurotoxic pesticide dieldrin activates a non receptor tyrosine kinase to promote PKCδ-mediated dopaminergic apoptosis in a dopaminergic neuronal cell model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Neurotoxic methamphetamine regimen severely impairs recognition memory in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Reduced cortical thickness is associated with the glutamatergic regulatory gene risk variant DAOA Arg30Lys in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Failure to Recognize Novelty after Extended Methamphetamine Self-Administration Results from Loss of Long-Term Depression in the Perirhinal Cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Roles of thioredoxin reductase 1 and APE/Ref-1 in the control of basal p53 stability and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Prolonged exposure of rats to intravenous methamphetamine: behavioral and neurochemical characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Neurotoxicity in dopamine and 5-hydroxytryptamine terminal fields: a regional analysis in nigrostriatal and mesolimbic projections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Brain serotonin transporter density and aggression in abstinent methamphetamine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine causes microglial activation in the brains of human abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

In vivo imaging of mitochondrial function in methamphetamine-treated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Ginsenosides attenuate methamphetamine-induced behavioral side effects in mice via activation of adenosine A2A receptors: possible involvements of the striatal reduction in AP-1 DNA binding activity and proenkephalin gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Role of microsomal epoxide hydrolase in methamphetamine-induced drug dependence in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

PKCδ inhibition enhances tyrosine hydroxylase phosphorylation in mice after methamphetamine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Role of oxidative stress in methamphetamine-induced dopaminergic toxicity mediated by protein kinase Cδ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Ginsenoside Re rescues methamphetamine-induced oxidative damage, mitochondrial dysfunction, microglial activation, and dopaminergic degeneration by inhibiting the protein kinase Cδ gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

N-Methyl, N-propynyl-2-phenylethylamine (MPPE), a Selegiline Analog, Attenuates MPTP-induced Dopaminergic Toxicity with Guaranteed Behavioral Safety: Involvement of Inhibitions of Mitochondrial Oxidative Burdens and p53 Gene-elicited Pro-apoptotic C

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

A single neurotoxic dose of methamphetamine induces a long-lasting depressive-like behaviour in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Cognitive impairment in individuals currently using methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Cognitive performance of current methamphetamine and cocaine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

The effect of relapse on cognition in abstinent methamphetamine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Perseverative behavior in rats with methamphetamine-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Treatment of mice with methamphetamine produces cell loss in the substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Transcription-independent p53 apoptosis: an alternative route to death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor- alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Psychotic symptoms in methamphetamine psychotic in-patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

The N terminus of monoamine transporters is a lever required for the action of amphetamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Mechanisms of neurotransmitter release by amphetamines: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

A dual approach to self-stimulation and locomotor trace affected by chronic methamphetamine treatment for an animal model of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Chronic stress enhances methamphetamine-induced extracellular glutamate and excitotoxicity in the rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Human immunodeficiency virus-1 protein tat and methamphetamine interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

MK-801 and dextromethorphan block microglial activation and protect against methamphetamine-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Structural abnormalities in the brains of human subjects who use methamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Neurotoxic effects of methamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine-induced dopaminergic toxicity prevented owing to the neuroprotective effects of salicylic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Adults with a history of illicit amphetamine use exhibit abnormal substantia nigra morphology and parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

N-terminus regulation of VMAT2 mediates methamphetamine-stimulated efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Reduction of nuclear peroxisome proliferator-activated receptor gamma expression in methamphetamine-induced neurotoxicity and neuroprotective effects of ibuprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Stimulant-induced psychosis and schizophrenia: the role of sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Alpha-methyltyrosine attenuates and reserpine increases methamphetamine-induced neuronal changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Total antioxidant capacity is significantly lower in cocaine-dependent and methamphetamine-dependent patients relative to normal controls: results from a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Subpicomolar diphenyleneiodonium inhibits microglial NADPH oxidase with high specificity and shows great potential as a therapeutic agent for neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson's disease models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Oxidative activation of antioxidant defence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Protective effects of pseudoginsenoside-F11 on methamphetamine-induced neurotoxicity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Baicalein attenuates methamphetamine-induced loss of dopamine transporter in mouse striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Enhanced oxidative stress and aberrant mitochondrial biogenesis in human neuroblastoma SH-SY5Y cells during methamphetamine induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

S-Nitrosylating protein disulphide isomerase mediates α-synuclein aggregation caused by methamphetamine exposure in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Melatonin treatment during the incubation of sensitization attenuates methamphetamine-induced locomotor sensitization and MeCP2 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

A receptor mechanism for methamphetamine action in dopamine transporter regulation in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

The dopamine D1 receptor agonist, but not the D2 receptor agonist, induces gene expression of Homer 1a in rat striatum and nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

PKCdelta signaling: mechanisms of DNA damage response and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Effects of adenosine A1- and A2A-receptor agonists on enhancement of dopamine release from the striatum in methamphetamine-sensitized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Studies of amphetamine or methamphetamine psychosis in Japan: relation of methamphetamine psychosis to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Susceptibility to subsequent episodes in spontaneous recurrence of methamphetamine psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Clinical features, course and treatment of methamphetamine-induced psychosis in psychiatric inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

N-acetylcysteine amide protects against methamphetamine-induced tissue damage in CD-1 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0897-Y

10.1007/S12272-017-0897-Y

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28243833%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

1 reference